ContiVir30

Single-use Continuous Bioreactor for Virus Particles

ContiVir30

Single-use tubular bioreactor for the continuous production

of virus particles for vaccine and gene therapy applications

ContiVir30 is a continuous tubular bioreactor (CTB) that enables production of virus particles at the 1–100 L scale without increasing vessel size.

 

​Our current ContiVir30 CTB system has been used successfully for the production of:

  • Influenza A virus

  • Adeno-associated virus (AAV)

  • Non-infectious coronavirus-like particles (VLP) resembling SARS-CoV-2

A list of four good reasons to try ContiVir30 for production of your new virus strain:

  • Stability. Does not accumulate defective interfering particles and thus provides stable virus titers.

  • Reduced mutation risk. It allows a defined residence time and thus avoids virus mutations.

  • Throughput. It is twice as fast as batch due to its increased virus production rate.

  • Flexibility. Its single-use design minimizes downtime. 

Contact us with the formular if you wish to try the benefits of ContiVir30 or if you wish to invest in its development for your particular application.

CTB linkedin.jpg

Thank you for your message. We will contact you back shortly.